Navigation Links
Study: Treating Sleep Disorder May Thwart Heart Disease
Date:12/5/2012

WEDNESDAY, Dec. 5 (HealthDay News) -- People with obstructive sleep apnea have the same early cardiovascular damage as people with diabetes, a small new study finds.

Obstructive sleep apnea -- a common disorder marked by disrupted breathing during sleep -- increases the risk of high blood pressure, heart rhythm disorders, heart attack, stroke, sudden cardiac death and heart failure.

"There are not enough studies in the medical literature on early cardiovascular dysfunction in patients with [obstructive sleep apnea], when active steps can be taken to prevent progression to heart failure," study author Dr. Raluca Mincu of Bucharest, Romania, said in a European Society of Cardiology news release.

Because obstructive sleep apnea leads to many cardiovascular disorders, the researchers compared early cardiovascular dysfunction in sleep apnea patients and patients with diabetes, which is a typical risk factor for cardiovascular disease, Mincu added.

The study included 20 patients with moderate to severe obstructive sleep apnea, 20 patients with treated type 2 diabetes and 20 healthy people. They underwent tests to assess the condition of their arteries.

"Patients with moderate to severe [obstructive sleep apnea] had endothelial dysfunction and higher arterial stiffness than [the healthy people], and their results were similar to patients with diabetes," Mincu said. This suggests that obstructive sleep apnea is associated with a high risk for cardiovascular disease, Mincu added.

Endothelial dysfunction means that the inner lining of blood vessels does not function normally.

The study was scheduled for presentation this week at the annual meeting of the European Association of Cardiovascular Imaging in Athens, Greece.

"Patients should realize that behind snoring there can be a serious cardiac pathology and they should get referred to a sleep specialist," Mincu said. "If they are diagnosed with obstructive sleep apnea, they are at increased risk of cardiovascular disease and need to adopt a heart-healthy lifestyle to reduce that risk."

"Our study is a signal for cardiologists, pneumologists and general practitioners to work together to actively diagnose obstructive sleep apnea, administer the appropriate treatment (continuous positive airway pressure -- CPAP) and assess arterial function," Mincu concluded. "This will help avoid progression of early cardiovascular dysfunction through to heart failure, the final stage of heart disease."

Data and conclusions presented at meetings are typically considered preliminary until published in a peer-reviewed medical journal.

More information

The U.S. National Heart, Lung, and Blood Institute has more about sleep apnea.

-- Robert Preidt

SOURCE: European Society of Cardiology, news release, Dec. 5, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Study: Women not getting enough exercise; at risk of developing metabolic syndrome
2. Study: Insomnia takes toll on tinnitus patients
3. Study: No link between depression, nasal obstruction
4. Study: More Pre-Teens Get Vaccines When Middle Schools Require Them
5. Study: Kids Who Sleep in Parents Bed Less Likely to Be Overweight
6. OHSU study: Misdiagnosis of MS is costing health system millions per year
7. UW study: Sleep apnea associated with higher mortality from cancer
8. Study: Heart damage after chemo linked to stress in cardiac cells
9. STeleR study: Telerehab improves functioning after stroke
10. Study: Willingness to be screened for dementia varies by age but not by sex, race or income
11. Study: 21 percent of newly admitted nursing home residents sustain a fall during their stay
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... 2016 , ... Nordic Naturals announces another breakthrough innovation—Omega Curcumin, ... synergistic combination of omega-3 fatty acids and potent antioxidants contains 1000 mg concentrated ... and 200 mg of N-Acetylcysteine (NAC). , Each nutrient plays a distinct ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... pharmacy industry, today announced that it was chosen as the Pharmaceutical News Provider ... Awards . The awards acknowledge the hard work and dedication of community members ...
(Date:5/4/2016)... ... May 04, 2016 , ... AudioEducator is the country's top ... months, AudioEducator has lined up some informative training session for the medical coding ... compliance know-how and practical, easy-to-apply advice. , On Thursday, May 19, AudioEducator will ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... Patient 2016, a powerful cellular therapy software application that helps blood and ... to patients. , Since Transtem’s initial launch, Mediware has continued to enhance core ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... Fertility Centers ... at 535 Ocean Ave. Their new Maine Fertility Center provides convenient access to care ... Anne Rainville and her staff at Women’s Wellness Comprehensive Care in Portland,” said Fertility ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... ZIONA, Israel , May 4, ... TASE: BVXV) announced today that BiondVax,s CEO, Dr. Ron ... conference in New York City . ... at 10:30am at Pioneers 2016, a conference presented by ... York Palace Hotel. The BiondVax presentation that Dr. ...
(Date:5/4/2016)... , May 4, 2016 ... Jerusalem announced today that it had signed an ... Inc. , developer of novel protein degradation and immunomodulatory ... and commercialization of drug candidates representing first-in-class therapy for ... were not disclosed. The novel technology was ...
(Date:5/4/2016)... 2016 Valeritas Holdings, Inc. (OTCQB: ... public offering (APO). This was accomplished via a reverse ... and a private placement of approximately 5 million shares ... Under the terms of the reverse merger, ... Inc. will trade on the OTC Markets under the ...
Breaking Medicine Technology: